Chronic Kidney Disease Stage 3
20
4
6
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
10.0%
2 terminated out of 20 trials
77.8%
-8.7% vs benchmark
20%
4 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (20)
Effects of Replacing High Protein Foods in People With Chronic Kidney Disease
A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes
KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients.
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
Urinary Tubular Biomarkers for Chronic Kidney Disease
Clinical Effectiveness of MyNutriKidney®
Preserving Kidney Function in Children With Chronic Kidney Disease
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
Empowering Veterans to Communicate With Healthcare Providers
Desidustat in the Treatment of Anemia in CKD
The Association Between the Duration of Acute Kidney Injury and New-onset Chronic Kidney Disease After Cardiac or Thoracic Aortic Surgery
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients
Assessing Perceived Versus Actual Knowledge and Quality of Life in Pre-Dialysis Chronic Kidney Disease (CKD) Patients
Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol
Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients